Use of cell-permeable peptides to prevent neuronal degeneration.
about
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's DiseaseNMDA and dopamine converge on the NMDA-receptor to induce ERK activation and synaptic depression in mature hippocampusThe JNK inhibitor XG-102 protects against TNBS-induced colitis.Bag1-L is a phosphorylation-dependent coactivator of c-Jun during neuronal apoptosis.Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain.Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain modelThe c-jun kinase/stress-activated pathway: regulation, function and role in human disease.Role of JNK isoforms in the development of neuropathic pain following sciatic nerve transection in the mouse.Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophages.Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases.Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathwayThe glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatmentDevelopment of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicityJNK Regulation of Depression and Anxiety
P2860
Q26770431-49781080-6C66-4D4C-A7E1-E1EEA3DB4FFAQ28469102-012FD31A-A620-4DA8-BB4B-4C6939B8A22AQ28481470-AD079A7A-18A0-40B6-82CA-E4B087832D1BQ28589005-344D004B-FDBB-41E9-9BB4-F1503FEF8AAFQ30437957-B2BC18AD-2294-4EB0-8998-FB5BD301AE1BQ30487130-BD335FB6-1A0B-4F2E-A1B9-6AD26E0B2BA3Q30500831-06BF7D30-A4F4-49B7-B2D7-29C0664B448FQ30524828-538EDDB5-05E0-4CA1-86E4-C961CA0A6D93Q34032309-6219115E-64E4-4B02-9A51-8C7AE7B0DEEEQ36022319-D4B72A9F-C1DF-4216-94B4-2FDF4AD14B3FQ36089269-A4837B58-311F-4CBB-970A-3A4617CC24F2Q36915045-D5434AB8-1C85-4620-9385-68E3887E68F8Q38213709-36152BA1-448D-4164-BFE4-A41948B063D8Q41193930-F0564106-994D-415F-B0D2-78F617E26305Q58790371-96F6976F-D74F-40FA-866C-3ED6480DBFCD
P2860
Use of cell-permeable peptides to prevent neuronal degeneration.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Use of cell-permeable peptides to prevent neuronal degeneration.
@ast
Use of cell-permeable peptides to prevent neuronal degeneration.
@en
type
label
Use of cell-permeable peptides to prevent neuronal degeneration.
@ast
Use of cell-permeable peptides to prevent neuronal degeneration.
@en
prefLabel
Use of cell-permeable peptides to prevent neuronal degeneration.
@ast
Use of cell-permeable peptides to prevent neuronal degeneration.
@en
P1476
Use of cell-permeable peptides to prevent neuronal degeneration
@en
P2093
Christophe Bonny
P304
P356
10.1016/J.MOLMED.2004.03.008
P577
2004-05-01T00:00:00Z